AMSTERDAM (Dow Jones)--Dutch life and materials sciences group Royal DSM NV (DSM.AE) Tuesday said it will make a recommended $1.09 billion cash takeover bid for U.S. nutrition company Martek Biosciences Corp. (MATK), because it wants to expand its product offering in the infant nutrition, food and beverage and dietary supplements markets.
